Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Parkinson's disease is costing societies billions — and the bill is only growing. A new European study pegged the continent's 2019 PD burden at €22.8 billion (~$26.5B), while U.S. costs hit an estimated $82.2 billion in 2024. Experts say earlier intervention, exercise as a prescribed treatment, and stronger caregiver support policies could help bend the curve.
Parkinson's disease is quietly becoming one of the most expensive neurological conditions on the planet. A study in Movement Disorders estimated that PD cost 47 European countries €22.8 billion (~$26.5B) in 2019 — with nearly 1 in every 5 euros representing unpaid care by family members. In the U.S., the picture is similarly sobering: a 2026 analysis put the annual burden at $82.2 billion, with projections suggesting costs could exceed $79 billion by 2037 as prevalence climbs past 1.6 million Americans.
Cleveland Clinic neurologist Dr. Zoltan Mari says the trajectory is driven by aging populations, longer survival with PD, better diagnosis, and rising healthcare prices. He argues that exercise should be treated as a core medical intervention — not a lifestyle suggestion — citing updated 2026 guidelines from the Parkinson's Foundation and the American College of Sports Medicine. Earlier referrals to physical, occupational, and speech therapy, along with integrated palliative care, can also reduce costly hospitalizations and complications.
By the Numbers:
Why it matters: Parkinson's isn't just a medical challenge — it's a growing economic and social crisis. Without systemic changes in how care is delivered, reimbursed, and supported at home, the burden on patients, families, and health systems will only intensify.
